USP

United States Pharmacopeia

United States / InternationalNorth AmericaCompendial body

Compendial standards body; its General Chapters carry the force of law under the FD&C Act.

Browse the USP standards →Official site ↗

What this page does not claim

SPEQ curates and cross-references these bodies. It is not affiliated with, accredited by, or endorsed by any of them, and a count of decoded standards is a measure of SPEQ’s coverage, not of a body’s importance.

WHAT USP COVERS

The United States Pharmacopeia is a non-governmental standards-setting organisation that publishes the USP–NF, containing monographs for drug substances, products, excipients, and dietary supplements, together with general chapters describing tests and practices.

WHAT USP PUBLISHES

  1. 01USP–NF monographs for substances, products, excipients, and supplements
  2. 02General chapters below <1000> — enforceable, e.g. <71> sterility, <85> bacterial endotoxins, <61>/<62> microbial enumeration
  3. 03General chapters <1000> and above — informational, e.g. <1116> aseptic environments, <1117> microbiological best practices
  4. 04Reference standards used to calibrate and validate analytical methods
  5. 05Pending revisions through Pharmacopeial Forum for public comment

HOW ITS REQUIREMENTS BITE

USP does not inspect, but its standards are enforceable in the US: under the FD&C Act a drug recognised in the compendium that fails to conform to its monograph standards may be deemed adulterated or misbranded. The distinction between general chapters matters — those numbered below <1000> are potentially enforceable requirements, while those numbered <1000> and above are informational.

What practitioners get wrong

  • The <1000> boundary is the single most useful thing to know: below is enforceable, above is guidance.
  • USP, Ph. Eur., and JP monographs are harmonised only in part — never assume equivalence without checking.
  • Monographs are living documents; verify you are working from the current official version.
  • Compendial compliance is a floor, not a ceiling — your specification may need to be tighter.

WHERE IT SITS INTERNATIONALLY

USP participates in the Pharmacopoeial Discussion Group with the European and Japanese pharmacopoeias, which has harmonised a subset of general chapters and excipient monographs — but only a subset.

USP STANDARDS SPEQ DECODES · 15

USP <1116>HIGH INSPECTION RISK
Microbiological Control and Monitoring of Aseptic Processing Environments
USP <1117>
Microbiological Best Laboratory Practices
USP <1058>
Analytical Instrument Qualification
USP <61>/<62>
Microbiological Examination of Nonsterile Products
USP <795>HIGH INSPECTION RISK
Pharmaceutical Compounding — Nonsterile Preparations
USP <797>HIGH INSPECTION RISK
Pharmaceutical Compounding — Sterile Preparations
USP <800>HIGH INSPECTION RISK
Hazardous Drugs — Handling in Healthcare Settings
USP <1223>
Validation of Alternative Microbiological Methods
USP <665>
Plastic Components and Systems Used to Manufacture Pharmaceutical Drug Products
USP <1207>
Package Integrity Evaluation — Sterile Products
USP <1220>
Analytical Procedure Life Cycle
USP <232>/<233>HIGH INSPECTION RISK
Elemental Impurities — Limits and Procedures
USP <1079>
Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products
USP <2750>
Manufacturing Practices for Dietary Supplements
USP <825>
Radiopharmaceuticals — Preparation, Compounding, Dispensing, and Repackaging

DISCIPLINES IN USP’S REMIT

GMPGood Manufacturing PracticeGDPGood Distribution PracticeGEPGood Engineering Practice
TOPIC EXPLAINERS CITING USP STANDARDS
Contamination Control & Annex 1 →
The Contamination Control Strategy, cleanroom classification, and the 2022 Annex 1 revision.
Media Fill & Aseptic Process Simulation →
How aseptic process simulation validates that a sterile process keeps product sterile — design, acceptance criteria, and the interventions that decide the result.
Bioburden & Microbial Control →
The viable microbial load a product carries before sterilisation — what it drives, how it is tested (USP <61>/<62>, <1116>), and why limits and trends matter.
Equipment Qualification (IQ / OQ / PQ) →
What DQ, IQ, OQ, and PQ each actually prove, why USP <1058> qualifies a lab instrument differently from a mixer, and how the classical four-stage model relates to the risk-based C&Q approach.
Environmental Monitoring (EM) →
The programme that proves a cleanroom’s controlled state actually holds during production — viable and non-viable, why a single Grade A recovery is not a normal result, and the alert-vs-action-limit distinction people get wrong.
Analytical Method Lifecycle (ICH Q2/Q14) →
Validation is not a one-time gate at the end — ICH Q14 reframed a method as something developed, validated, and managed across a lifecycle, and it changed what a post-approval method change requires.
Single-Use Systems →
Disposable process equipment in biomanufacturing — extractables/leachables, integrity, and supply-chain qualification.
Rapid Microbiological Methods →
Faster alternatives to growth-based micro testing — how RMMs work, and how to validate them against the compendial method.
Depyrogenation →
Removing or inactivating bacterial endotoxin from containers, components, and equipment surfaces before they meet a sterile product.
Bacterial Endotoxins Test →
The LAL-based assay used to detect and quantify bacterial endotoxin in parenteral products, water systems, and components.
Sterility Testing →
The compendial test used to verify the absence of viable microorganisms in a sterile product batch, and why a pass does not prove sterility assurance.
Visual Inspection & Particulates →
The 100% and statistical inspection programs that catch visible particulate matter and container defects before a sterile product is released.
Disinfectant Efficacy Qualification →
How cleanroom disinfectants are selected, rotated, and proven — against real surfaces and real organisms — to actually reduce bioburden.
Aseptic Gowning & Technique →
How personnel are qualified to enter classified aseptic environments without becoming the contamination source they are being protected from.
Personnel & Viable Monitoring →
The gloved-finger, gown-surface, and viable air sampling program that tracks whether personnel are staying within their qualified contamination limits.
Dissolution Testing →
The compendial in-vitro test that measures how much drug substance releases from a dosage form over time, and why it is one of the most heavily inspected assays in pharma.
Analytical Method Transfer →
The documented process of demonstrating a receiving laboratory can execute an already-validated analytical method with equivalent performance to the originating laboratory.
Process Instrumentation & Measurement →
Every control action and recorded value begins at an instrument — and a correctly calibrated one can still be wrongly installed.
Laboratory Network & Operating Model →
Testing scattered across laboratories with different quality systems produces results that are individually defensible and collectively inconsistent.
Sampling Plans, Specifications & Standards →
A result describes the sample — and the sample describes the batch only if the plan makes it representative.
Metrology & Calibration Management →
A calibration failure is retrospective by nature — which is why the as-found condition matters more than the as-left one.
Laboratory Capacity, Flow & Turnaround →
A laboratory running permanently at capacity has no slack for an investigation — which is exactly when it will be asked to do one.
Occupational Safety in Regulated Manufacturing →
Personal protection and product protection are the same gowning decision made for two reasons — and they can conflict.
Potent Compounds & Specialised Hazards →
One toxicological assessment, two obligations — the limits driving cleaning validation and containment come from the same work.

USP: frequently asked questions

Reference answers on United States Pharmacopeia’s mandate, what it publishes, and how its requirements acquire force.

What is the USP–NF?

The United States Pharmacopeia is a non-governmental standards-setting organisation that publishes the USP–NF, containing monographs for drug substances, products, excipients, and dietary supplements, together with general chapters describing tests and practices. It does not inspect.

Are USP general chapters enforceable?

It depends on the number. General chapters numbered below <1000> are potentially enforceable requirements; those numbered <1000> and above are informational. Under the FD&C Act, a compendial drug that fails to conform to its monograph standards may be deemed adulterated or misbranded.

Are USP, Ph. Eur., and JP monographs equivalent?

Only in part. USP participates in the Pharmacopoeial Discussion Group with the European and Japanese pharmacopoeias, which has harmonised a subset of general chapters and excipient monographs — but only a subset. Never assume equivalence without checking, and compendial compliance is a floor, not a ceiling.